These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6294999)

  • 21. [Application of non-glycoside inotropic agents in newborn infants].
    Umans-Eckenhausen MA; Terlouw JF; Szatmari A; van den Anker JN
    Tijdschr Kindergeneeskd; 1993 Feb; 61(1):13-20. PubMed ID: 8493697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic therapy of congestive cardiomyopathy: effects of prenalterol and digoxin].
    Schwarz KR; Hofmann M; Mäurer W; Kadel C; von Olshausen K; Rauch B; Kübler W
    Z Kardiol; 1985 Jul; 74(7):374-83. PubMed ID: 3929486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.
    Reiz S; Waagstein F; Hjalmarson A
    Clin Cardiol; 1980 Apr; 3(2):96-105. PubMed ID: 6104553
    [No Abstract]   [Full Text] [Related]  

  • 24. Endogenous and exogenous catecholamines in critical care medicine.
    Chernow B; Rainey TG; Lake CR
    Crit Care Med; 1982 Jun; 10(6):409-16. PubMed ID: 7042207
    [No Abstract]   [Full Text] [Related]  

  • 25. Newer inotropic agents.
    Sharpe DN
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):215-8. PubMed ID: 6087050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
    Klein G; Sauer E; Bauer R; Wirtzfeld A; Sebening H
    Arzneimittelforschung; 1981; 31(1a):257-9. PubMed ID: 7195236
    [No Abstract]   [Full Text] [Related]  

  • 27. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
    Strauer BE; Bohn I; Hahn B; Kment A; Motz U
    J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical use of inotropic agents.
    Spores J; DeWood MA
    AANA J; 1979 Dec; 47(6):679-84. PubMed ID: 525231
    [No Abstract]   [Full Text] [Related]  

  • 30. Lack of functional influence by prenalterol through alpha 1-adrenoceptors in rat myocardium.
    Aass H; Hedberg A; Skomedal T; Carlsson E; Osnes JB
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):12-5. PubMed ID: 6310957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How is catecholamine therapy carried out in heart failure?].
    Reek S
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2087-8. PubMed ID: 12373645
    [No Abstract]   [Full Text] [Related]  

  • 32. [Alternatives to digitalis therapy].
    Larbig D; Nasse H
    Dtsch Med Wochenschr; 1983 Nov; 108(45):1725-9. PubMed ID: 6354664
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacological correction of low cardiac output syndrome in hemofiltration].
    Nikiforov IuV; Lebedeva RN
    Anesteziol Reanimatol; 1997; (3):87-9. PubMed ID: 9289999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Catecholamines in the treatment of therapy-refractory heart insufficiency].
    Doenecke P; Schmengler K
    ZFA (Stuttgart); 1981 Jul; 57(19):1367-71. PubMed ID: 7269763
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental studies on therapeutic modification of sparteine poisoning].
    Strubelt O
    Arzneimittelforschung; 1982; 32(10):1287-92. PubMed ID: 6891229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of prenalterol and dobutamine in a canine model of acute ischemic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    J Cardiovasc Pharmacol; 1981; 3(4):896-905. PubMed ID: 6167819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dopamine and dobutamine as circulatory drugs].
    Chodera A; Pieczyńska A; Chodera-Otuszewska R
    Pol Tyg Lek; 1983 Nov; 38(48):1505-7. PubMed ID: 6679072
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dobutamine in low cardiac output syndrome. Haemodynamic study (author's transl)].
    Montero Benzo R; Vicente Sánchez JL; Alepuz Ferrer R
    Rev Esp Anestesiol Reanim; 1981 Sep; 28(5):283-8. PubMed ID: 7330374
    [No Abstract]   [Full Text] [Related]  

  • 39. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 40. Dobutamine: a new synthetic cardioactive sympathetic amine.
    Sonnenblick EH; Frishman WH; LeJemtel TH
    N Engl J Med; 1979 Jan; 300(1):17-22. PubMed ID: 362214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.